Inhibitex to Host Conference Call to Report Fourth Quarter and Year-End 2009 Financial Results on March 23, 2010
March 09 2010 - 10:05AM
Business Wire
Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host
a conference call on Tuesday, March 23, 2010 at 9:00 a.m. EST to
review the Company’s fourth quarter and year-end December 31, 2009
financial results and provide an update on recent corporate
developments. The Company will issue a press release regarding its
financial results on the same day, prior to the conference
call.
Webcast Information
To access the conference call, please dial 877-407-8031
(domestic) or 201-689-8031 (international). A replay of the call
will be available from 11:00 a.m. Eastern Time on March 23rd until
April 23, 2010 at midnight. To access the replay, please dial
877-660-6853 (domestic) or 201-612-7415 (international) and
reference the account # 286 and the conference id # 346800. A live
audio webcast of the call and the archived webcast will be
available in the News and Events section of the Inhibitex website
at http://www.inhibitex.com.
About Inhibitex
Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company focused on developing products to treat
serious infectious diseases. The Company’s pipeline includes
FV-100, which is in Phase II clinical development for the treatment
of shingles, and INX-189, a nucleotide polymerase inhibitor for the
treatment of chronic hepatitis C infections. The Company also has
additional HCV nucleotide polymerase inhibitors in preclinical
development and has licensed the use of its proprietary MSCRAMM®
protein platform to Pfizer for the development of staphylococcal
vaccines. For additional information about the Company, please
visit www.inhibitex.com.
For additional information about the Company, please visit
www.inhibitex.com.
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024